Abacus Planning Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $338K | Sell |
1,531
-25
| -2% | -$6.92K | 0.04% | 188 |
|
|
2026
Q1 | $460K | Sell |
1,556
-20
| -1% | -$5.94K | 0.06% | 149 |
|
|
2025
Q4 | $430K | Sell |
1,576
-19
| -1% | -$5.16K | 0.06% | 154 |
|
|
2025
Q3 | $431K | Sell |
1,595
-7
| -0.4% | -$1.91K | 0.06% | 144 |
|
|
2025
Q2 | $442K | Sell |
1,602
-8
| -0.5% | -$2.18K | 0.07% | 137 |
|
|
2025
Q1 | $427K | Buy |
1,610
+31
| +2% | +$7.65K | 0.07% | 128 |
|
|
2024
Q4 | $367K | Sell |
1,579
-14
| -0.9% | -$3.22K | 0.06% | 142 |
|
|
2024
Q3 | $351K | Buy |
1,593
+413
| +35% | +$85.5K | 0.06% | 151 |
|
|
2024
Q2 | $232K | Hold |
1,180
| – | – | 0.05% | 185 |
|
|
2024
Q1 | $254K | Hold |
1,180
| – | – | 0.05% | 175 |
|
|
2023
Q4 | $249K | Sell |
1,180
-16
| -1% | -$3.41K | 0.05% | 164 |
|
|
2023
Q3 | $239K | Buy |
1,196
+16
| +1% | +$3.18K | 0.06% | 156 |
|
|
2023
Q2 | $219K | Hold |
1,180
| – | – | 0.05% | 173 |
|
|
2023
Q1 | $226K | Buy |
+1,180
| New | +$213K | 0.06% | 163 |
|
|
2022
Q4 | – | Sell |
-1,202
| Closed | -$213K | – | 185 |
|
|
2022
Q3 | $213K | Sell |
1,202
-204
| -15% | -$40.3K | 0.06% | 157 |
|
|
2022
Q2 | $288K | Sell |
1,406
-15
| -1% | -$3.18K | 0.08% | 137 |
|
|
2022
Q1 | $338K | Hold |
1,421
| – | – | 0.09% | 141 |
|
|
2021
Q4 | $325K | Buy |
1,421
+37
| +3% | +$8.14K | 0.09% | 146 |
|
|
2021
Q3 | $268K | Sell |
1,384
-136
| -9% | -$27.6K | 0.09% | 151 |
|
|
2021
Q2 | $323K | Sell |
1,520
-915
| -38% | -$193K | 0.1% | 132 |
|
|
2021
Q1 | $497K | Buy |
2,435
+15
| +0.6% | +$2.95K | 0.16% | 97 |
|
|
2020
Q4 | $441K | Sell |
2,420
-300
| -11% | -$51K | 0.14% | 102 |
|
|
2020
Q3 | $455K | Buy |
2,720
+50
| +2% | +$8.42K | 0.17% | 93 |
|
|
2020
Q2 | $434K | Sell |
2,670
-8
| -0.3% | -$1.43K | 0.18% | 90 |
|
|
2020
Q1 | $463K | Sell |
2,678
-105
| -4% | -$20.9K | 0.23% | 78 |
|
|
2019
Q4 | $559K | Hold |
2,783
| – | – | 0.26% | 79 |
|
|
2019
Q3 | $588K | Buy |
2,783
+1,150
| +70% | +$240K | 0.29% | 70 |
|
|
2019
Q2 | $317K | Buy |
1,633
+326
| +25% | +$60.1K | 0.19% | 110 |
|
|
2019
Q1 | $215K | Hold |
1,307
| – | – | 0.13% | 137 |
|
|
2018
Q4 | $246K | Buy |
+1,307
| New | +$241K | 0.19% | 115 |
|
Other funds holding CME
Abacus Planning Group's CME Position: Q2 2026 in Review
Abacus Planning Group reduced its CME Group (CME) stake by 1.6% in Q2 2026, selling an estimated $6.92K and leaving 1,531 shares worth $338K. The position accounts for 0.04% of the portfolio, ranked #188.
Abacus Planning Group first reported a position in CME in Q4 2018 and has held it in 30 quarters since. The position peaked at $588K in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Abacus Planning Group held 1,531 shares of CME Group worth $338K as of Q2 2026.
- Abacus Planning Group sold 25 CME Group shares in Q2 2026, an estimated $6.92K.
- CME Group made up 0.04% of Abacus Planning Group's portfolio in Q2 2026, its #188 holding.
- Abacus Planning Group first reported a position in CME Group in Q4 2018 and has held it in 30 quarters since.
- Abacus Planning Group's CME Group position peaked at $588K in Q3 2019.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.